Fatty15 C15:0 ペンタデカン酸サプリメント 長寿栄養素 - 90 ビーガンカプセル - 魚油オメガ3サプリメントの3xセルラー利点 - 腸の健康、肝臓サポート、およびミトコンドリア健康
- POWERED BY C15:0 (PENTADECANOIC ACID): The first essential fatty acid to be discovered in over 90 years. This award-winning longevity supplement, developed by scientists over 10 years in collaboration with the U.S. Navy, has 3x more cellular benefits than pure omega-3 (EPA). C15:0 strengthens cells by 80%, improves mitochondrial function by 45% and repairs cells to slow aging-related breakdown and protect long-term health. Clinical Study References: Venn-Watson & Butterworth PLOS ONE 2022
- SUPPORTED GUT AND LIVER HEALTH: The pure C15:0 ingredient in fatty15 has been studied for its potential to support C15:0 levels, gut microbiome balance, and liver function. Research has also explored its role in red blood cell health over 12 weeks. Clinical Study References: Robinson et al. J Nutrition 2024, Chooi et al. Am J Clin Nutrition 2024, Venn-Watson & Butterworth PLOS ONE 2022
- ALTERNATIVE TO OMEGA 3 FISH OIL, COQ10, UROLITHIN A, AND LIVER SUPPORT SUPPLEMENTS. Unlike COQ10 and urolithin A, which specifically target oxidative stress and mitochondrial function, fatty15 provides an essential nutrient with 36+ cellular benefits and is required by our bodies to uniquely strengthen cells, activate key longevity pathways, and target six hallmarks of cellular aging. Clinical Study References: Venn-Watson & Butterworth PLOS ONE 2022, Venn-Watson et al. Scientific Reports 2020
- MULTIPLE LONGEVITY-ENHANCING ACTIVITIES, including its role as an essential cell-strengthening and antioxidant supplement, providing whole-body support, including liver health. Unlike omega-3s, which are prone to lipid peroxidation and can weaken cell membranes, fatty15 resists oxidation and strengthens cells. Supports long-term health at its core, including its role as a fatty liver supplement. Clinical Studies: Venn-Watson & Schork Nutrients 2023, Venn-Watson et al. Scientific Reports 2020
- AWARD-WINNING LONGEVITY SUPPLEMENT: The groundbreaking discovery of C15:0 as an essential fatty acid, followed by the development of fatty15’s pure, optimized, and patented C15:0 longevity-supporting ingredient, were led by the doctors and scientists of fatty15. Clinical Study References: Venn-Watson & Schork Nutrients 2023, Venn-Watson et al. Scientific Reports 2020
重要情報
原料:
ペンタデカン酸、野菜セルロース
法的免責事項
栄養補助食品に関する声明はFDAによって評価されず、診断、治療、または病気や健康状態を防ぐものではありません。
パッケージ次元
7.56 x 5.31 x 3.62インチ; 11.99オンス
仕様設計
| 原料: | Egetable セルロース, ペンタデカン酸 |
| 有効期限 | 2019年7月20日 |
| 製品の利点 | メタボリズム管理 |
| 年齢範囲(記述) | アダルト |
| アイテムの数 | 1 |
| 容器ごとのサービング | 90 人 |
| トピックス | 850064163520の特長 |
| パッケージ情報 | ボトル |
| フレーバー | 不定休 |
| 項目 形態 | カプセル |
| 製品の種類 | 栄養補助食品 |
| 第一次補足のタイプ | ペンタデカン酸 |
| ブランド | 脂肪15 |
| タグ | |
|---|---|
| タグ | |
ここにダイナミックスニペットが表示されます...
フィルタ及びお使いのテンプレートが提供されてないため、このメッセージが表示されました。